LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation

EMBO Journal

Volumn 30, Issue 11, 2011, Pages 2115-2129

  Verweij, Frederik J ^a   Van Eijndhoven, Monique A J ^a   Hopmans, Erik S ^a   Vendrig, Tineke ^a   Wurdinger, Tom ^b   Cahir Mcfarland, Ellen ^c   Kieff, Elliott ^c   Geerts, Dirk ^d   Van Der Kant, Rik ^e   Neefjes, Jacques ^e   Middeldorp, Jaap M ^a   Pegtel, D Michiel ^a  

^a Amsterdam Gastroenterology Metabolism   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

CD63; endosomes; exosomes; LMP1; NF B signalling

Indexed keywords

CD63 ANTIGEN; CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; SHORT HAIRPIN RNA; TETRASPANIN;

ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL SECRETION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOSOME; EXOSOME; GENETIC TRANSFECTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIPID RAFT; PRIORITY JOURNAL; RNA INTERFERENCE; UBIQUITINATION;

ANTIGENS, CD; CELL LINE; ENDOSOMES; EXOSOMES; HERPESVIRUS 4, HUMAN; HUMANS; NF-KAPPA B; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 79957925099     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.123     Document Type: Article

References (79)

1. Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M (2008) B cell activation regulates exosomal HLA production. Eur J Immunol 38: 1423-1434
2. Aviel S, Winberg G, Massucci M, Ciechanover A (2000) Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J Biol Chem 275: 23491-23499 (Pubitemid 30624630)
3. Babcock GJ, Thorley-Lawson DA (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci USA 97: 12250-12255
4. Baichwal VR, Sugden B (1987) Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J Virol 61: 866-875 (Pubitemid 17040217)
5. Bonifacino JS, Traub LM (2003) Signals for sorting of transmem-brane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447 (Pubitemid 36930451)
6. Brooks JM, Lee SP, Leese AM, Thomas WA, Rowe M, Rickinson AB (2009) Cyclical expression of EBV latent membrane protein 1 in EBV-transformed B cells underpins heterogeneity of epitope presentation and CD8+ T cell recognition. J Immunol 182: 1919-1928
7. Buschow SI, Nolte-'t Hoen EN, van NG, Pols MS, ten BT, Lauwen M, Ossendorp F, Melief CJ, Raposo G, Wubbolts R, Wauben MH, Stoorvogel W (2009) MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10: 1528-1542
8. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E (2000) NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97: 6055-6060 (Pubitemid 30367522)
9. Ceccarelli S, Visco V, Raffa S, Wakisaka N, Pagano JS, Torrisi MR (2007) Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes. Int J Cancer 121: 1494-1506 (Pubitemid 47328708)
10. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ (2010) Exosome release of beta-catenin: a novel mechanism that antag-onizes Wnt signaling. J Cell Biol 190: 1079-1091
11. Chang CH, Fontes JD, Peterlin M, Flavell RA (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180: 1367-1374 (Pubitemid 24289610)
12. Coffin III WF, Geiger TR, Martin JM (2003) Transmembrane do-mains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis. J Virol 77: 3749-3758 (Pubitemid 36297293)
13. Dantuma NP, Groothuis TA, Salomons FA, Neefjes J (2006) A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J Cell Biol 173: 19-26
14. Davis RE, Brown KD, Siebenlist U, Staudt LM (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194: 1861-1874 (Pubitemid 34028664)
15. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK et al (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463: 88-92
16. De GA, Geminard C, Fevrier B, Raposo G, Vidal M (2003) Lipid raft-associated protein sorting in exosomes. Blood 102: 4336-4344 (Pubitemid 37494093)
17. Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W (2003) Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63: 2982-2989 (Pubitemid 36667173)
18. Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E, Middeldorp JM (2000) Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165: 663-670 (Pubitemid 30484731)
19. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. JBiol Chem 273: 20121-20127 (Pubitemid 28377568)
20. Fernandez-Borja M, Wubbolts R, Calafat J, Janssen H, Divecha N, Dusseljee S, Neefjes J (1999) Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity Curr Biol 9: 55-58 (Pubitemid 29045796)
21. Flanagan J, Middeldorp J, Sculley T (2003) Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol 84: 1871-1879 (Pubitemid 36805923)
22. Floettmann JE, Ward K, Rickinson AB, Rowe M (1996) Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline- regulated expression in B cell lines. Virology 223: 29-40 (Pubitemid 26302043)
23. Gauvreau ME, Cote MH, Bourgeois-Daigneault MC, Rivard LD, Xiu F, Brunet A, Shaw A, Steimle V, Thibodeau J (2009) Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic 10: 1518-1527
24. Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 16: 6131-6140 (Pubitemid 27458333)
25. Guasparri I, Bubman D, Cesarman E (2008) EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111: 3813-3820
26. Hammerschmidt W, Sugden B, Baichwal VR (1989) The transform-ing domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63: 2469-2475 (Pubitemid 19137519)
27. Hatzivassiliou EG, Kieff E, Mosialos G (2007) Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro. Leuk Res 31: 315-320 (Pubitemid 46073180)
28. Hemler ME (2005) Tetraspanin functions and associated microdo-mains. Nat Rev Mol Cell Biol 6: 801-811
29. Higuchi M, Izumi KM, Kieff E (2001) Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl Acad Sci USA 98: 4675-4680 (Pubitemid 32295035)
30. Hiscott J, Kwon H, Genin P (2001) Hostile takeovers: viral appro-priation of the NF-kappaB pathway J Clin Invest 107: 143-151 (Pubitemid 32096827)
31. Homig-Holzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Muller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U (2008) Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis. J Exp Med 205: 1317-1329 (Pubitemid 351831489)
32. Houali K, Wang X, Shimizu Y Djennaoui D, Nicholls J, Fiorini S, Bouguermouh A, Ooka T (2007) A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncopro-teins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin CancerRes 13: 4993-5000 (Pubitemid 47502063)
33. Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18: 519-527 (Pubitemid 40478115)
34. Ikeda M, Longnecker R (2007) Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 360: 461-468 (Pubitemid 46482621)
35. Kaykas A, Worringer K, Sugden B (2001) CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J 20: 2641-2654 (Pubitemid 32938549)
36. Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquere S, Nishi N, Hirashima M, Middeldorp J, Busson P (2006) Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 6: 283
37. Lam N, Sugden B (2003) LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO J 22: 3027-3038 (Pubitemid 36758623)
38. Le CC, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J (2006a) EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Blood 107: 2070-2078 (Pubitemid 43289391)
39. Le NF, Andre M, Boucheix C, Rubinstein E (2006b) Membrane microdomains and proteomics: lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics 6: 6447-6454 (Pubitemid 46048385)
40. Lee DY, Sugden B (2008a) The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy Oncogene 27: 2833-2842 (Pubitemid 351620447)
41. Lee DY, Sugden B (2008b) The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synth-esis. Blood 111: 2280-2289 (Pubitemid 351451435)
42. Lee J, Sugden B (2007) A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1. J Virol 81: 9121-9130 (Pubitemid 47311455)
43. Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y Krogan NJ, Plemenitas A, Peterlin BM (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11: 110-122
44. Liebowitz D (1998) Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl JMed 338: 1413-1421 (Pubitemid 28221982)
45. Liu HP, Wu CC, Chang YS (2006) PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1. EMBO J 25: 4120-4130
46. Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E (2003) Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc Natl Acad Sci USA 100: 15595-15600 (Pubitemid 38021035)
47. Mann KP, Thorley-Lawson D (1987) Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J Virol 61: 2100-2108 (Pubitemid 17088920)
48. Martin J, Sugden B (1991) Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol 65: 3246-3258
49. Meckes Jr DG, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA 107: 20370-20375
50. Meij P, Vervoort MB, Aarbiou J, van DP, Brink A, Bloemena E, Meijer CJ, Middeldorp JM (1999) Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. JInfect Dis 179: 1108-1115 (Pubitemid 29196489)
51. Middeldorp JM, Pegtel DM (2008) Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 18: 388-396
52. Mobius W, van DE, Ohno-Iwashita Y, Shimada Y, Heijnen HF, Slot JW, Geuze HJ (2003) Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 4: 222-231 (Pubitemid 36665383)
53. Muntasell A, Berger AC, Roche PA (2007) Tcell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J 26: 4263-4272 (Pubitemid 47525155)
54. Nydegger S, Khurana S, Krementsov DN, Foti M, Thali M (2006) Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1. J Cell Biol 173: 795-807 (Pubitemid 46165586)
55. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Wurdinger T, Middeldorp JM (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107: 6328-6333
56. Piper RC, Katzmann DJ (2007) Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23: 519-547
57. Piper RC, Luzio JP (2007) Ubiquitin-dependent sorting of integral membrane proteins for degradation in lysosomes. Curr Opin Cell Biol 19: 459-465 (Pubitemid 47271964)
58. Pols MS, Klumperman J (2009) Trafficking and function of the tetraspanin CD63. Exp Cell Res 315: 1584-1592
59. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172 (Pubitemid 26113979)
60. Rocha N, Kuijl C, van der KR, Janssen L, Houben D, Janssen H, Zwart W, Neefjes J (2009) Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endo-some positioning. J Cell Biol 185: 1209-1225
61. Roughan JE, Thorley-Lawson DA (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83: 3968-3976
62. Roughan JE, Torgbor C, Thorley-Lawson DA (2010) Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol 84: 1158-1168
63. Schroder J, Lullmann-Rauch R, Himmerkus N, Pleines I, Nieswandt B, Orinska Z, Koch-Nolte F, Schroder B, Bleich M, Saftig P (2009) Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function. Mol Cell Biol 29:1083-1094
64. Soni V, Yasui T, Cahir-McFarland E, Kieff E (2006) LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB. J Virol 80: 10787-10793 (Pubitemid 44628924)
65. Staudt LM (2010) Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol 2: a000109
66. Stuffers S, Sem WC, Stenmark H, Brech A (2009) Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10: 925-937
67. Tellam J, Connolly G, Webb N, Duraiswamy J, Khanna R (2003) Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity. Blood 102: 4535-4540 (Pubitemid 37494121)
68. Temme S, Eis-Hubinger AM, McLellan AD, Koch N (2010) The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J Immunol 184: 236-243
69. Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the im-mune system. Nat Rev Immunol 1: 75-82 (Pubitemid 33741978)
70. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. NEngl JMed 350: 1328-1337 (Pubitemid 38375368)
71. Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N (2006) LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25: 288-297 (Pubitemid 43083690)
72. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M (2008) Ceramide triggers bud-ding of exosome vesicles into multivesicular endosomes. Science 319: 1244-1247 (Pubitemid 351323020)
73. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831-840
74. Wubbolts R, Fernandez-Borja M, Oomen L, Verwoerd D, Janssen H, Calafat J, Tulp A, Dusseljee S, Neefjes J (1996) Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 135: 611-622 (Pubitemid 26372919)
75. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W (2003) Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multi-vesicular body formation. J Biol Chem 278: 10963-10972 (Pubitemid 36792644)
76. Wurdinger T, Badr C, Pike L, de KR, Weissleder R, Breakefield XO, Tannous BA (2008) A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5: 171-173 (Pubitemid 351181745)
77. Xu W, Santini PA, Sullivan JS, He B, Shan M, Ball SC, Dyer WB, Ketas TJ, Chadburn A, Cohen-Gould L, Knowles DM, Chiu A, Sanders RW, Chen K, Cerutti A (2009) HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 10: 1008-1017
78. Yasui T, Luftig M, Soni V, Kieff E (2004) Latent infection membrane protein transmembrane FWLY is critical for intermolecular inter-action, raft localization, and signaling. Proc Natl Acad Sci USA 101: 278-283 (Pubitemid 38084241)
79. Zwart W, Griekspoor A, Kuijl C, Marsman M, van RJ, Janssen H, Calafat J, van HM, Janssen L, van LM, Jalink K, Neefjes J (2005) Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22: 221-233 (Pubitemid 40255713)